148 related articles for article (PubMed ID: 35152500)
1. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
Keegan A; Dennington PM; Dhondy N; Mulligan SP
Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin replacement in chronic lymphocytic leukaemia.
Bunch C
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immune globulin in chronic lymphocytic leukaemia.
Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
Boughton BJ; Jackson N; Lim S; Smith N
Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Visentin A; Molinari MC; Pravato S; Cellini A; Angotzi F; Cavaretta CA; Ruocco V; Imbergamo S; Piazza F; Proietti G; Mauro FR; Trentin L
Curr Oncol; 2022 Dec; 30(1):274-283. PubMed ID: 36661671
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
Jurlander J; Geisler CH; Hansen MM
Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
[TBL] [Abstract][Full Text] [Related]
7. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
[TBL] [Abstract][Full Text] [Related]
9. Trends in intravenous immunoglobulin use in New South Wales, Australia.
Wood JG; Heywood AE; Dennington PM; Lloyd AR; Ziegler JB
Intern Med J; 2024 Jan; 54(1):149-156. PubMed ID: 37488980
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): kinetics of immunoglobulin metabolism.
Chapel HM; Lee M
J Clin Immunol; 1992 Jan; 12(1):17-20. PubMed ID: 1551938
[TBL] [Abstract][Full Text] [Related]
11. Clinical usage of intravenous immunoglobulins in Auckland.
Lee YC; Woodfield DG; Douglas R
N Z Med J; 1998 Feb; 111(1060):48-50. PubMed ID: 9539915
[TBL] [Abstract][Full Text] [Related]
12. Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey.
Wong J; Wood EM; Crispin P; Weinkove R; McQuilten ZK;
Intern Med J; 2019 Mar; 49(3):358-363. PubMed ID: 30129248
[TBL] [Abstract][Full Text] [Related]
13. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous and subcutaneous immunoglobulin therapy].
Thon V
Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
[TBL] [Abstract][Full Text] [Related]
15. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
16. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
Abadeh A; Shehadeh S; Betschel S; Waserman S; Cameron DW; Cowan J
PLoS One; 2023; 18(11):e0294408. PubMed ID: 37971974
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
[TBL] [Abstract][Full Text] [Related]
19. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
Günther G; Dreger B
Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
Li YW; Chen H; Zhang Y; An YF; Tang XM; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):495-500. PubMed ID: 34102824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
